
A genetic test to determine if a newborn is at risk of becoming deaf after being treated with a common antibiotic has been recommended for use within the NHS under new draft guidance.
Clinical watchdog National Institute for Health and Care Excellence (Nice) has conditionally recommended the use of the genedrive kit, a diagnostic test for detecting a variant in babies that puts them at risk of hearing loss when treated with gentamicin.